Mitchell McLeod Pugh & Williams’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $545K | Buy |
2,570
+76
| +3% | +$14.9K | 0.07% | 204 |
|
|
2026
Q1 | $489K | Hold |
2,494
| – | – | 0.07% | 199 |
|
|
2025
Q4 | $476K | Hold |
2,494
| – | – | 0.07% | 199 |
|
|
2025
Q3 | $445K | Buy |
2,494
+86
| +4% | +$15.3K | 0.07% | 194 |
|
|
2025
Q2 | $432K | Buy |
2,408
+1
| +0% | +$174 | 0.08% | 197 |
|
|
2025
Q1 | $407K | Buy |
2,407
+1
| +0% | +$164 | 0.08% | 194 |
|
|
2024
Q4 | $363K | Sell |
2,406
-730
| -23% | -$114K | 0.08% | 198 |
|
|
2024
Q3 | $487K | Buy |
3,136
+1
| +0% | +$149 | 0.1% | 180 |
|
|
2024
Q2 | $429K | Buy |
3,135
+1
| +0% | +$137 | 0.1% | 181 |
|
|
2024
Q1 | $417K | Buy |
3,134
+1
| +0% | +$130 | 0.1% | 179 |
|
|
2023
Q4 | $432K | Hold |
3,133
| – | – | 0.11% | 166 |
|
|
2023
Q3 | $382K | Buy |
3,133
+1
| +0% | +$133 | 0.11% | 173 |
|
|
2023
Q2 | $440K | Sell |
3,132
-139
| -4% | -$19.2K | 0.13% | 161 |
|
|
2023
Q1 | $463K | Hold |
3,271
| – | – | 0.14% | 157 |
|
|
2022
Q4 | $512K | Buy |
3,271
+191
| +6% | +$27.4K | 0.17% | 139 |
|
|
2022
Q3 | $378K | Hold |
3,080
| – | – | 0.15% | 151 |
|
|
2022
Q2 | $410K | Hold |
3,080
| – | – | 0.16% | 142 |
|
|
2022
Q1 | $422K | Hold |
3,080
| – | – | 0.14% | 158 |
|
|
2021
Q4 | $533K | Hold |
3,080
| – | – | 0.18% | 138 |
|
|
2021
Q3 | $448K | Buy |
3,080
+30
| +1% | +$4.39K | 0.17% | 147 |
|
|
2021
Q2 | $403K | Hold |
3,050
| – | – | 0.16% | 153 |
|
|
2021
Q1 | $391K | Hold |
3,050
| – | – | 0.16% | 150 |
|
|
2020
Q4 | $363K | Hold |
3,050
| – | – | 0.17% | 149 |
|
|
2020
Q3 | $349K | Hold |
3,050
| – | – | 0.18% | 137 |
|
|
2020
Q2 | $348K | Buy |
3,050
+130
| +4% | +$13.8K | 0.2% | 135 |
|
|
2020
Q1 | $234K | Buy |
2,920
+230
| +9% | +$23.8K | 0.18% | 149 |
|
|
2019
Q4 | $287K | Hold |
2,690
| – | – | 0.18% | 149 |
|
|
2019
Q3 | $288K | Hold |
2,690
| – | – | 0.2% | 151 |
|
|
2019
Q2 | $274K | Hold |
2,690
| – | – | 0.19% | 154 |
|
|
2019
Q1 | $242K | Hold |
2,690
| – | – | 0.17% | 155 |
|
|
2018
Q4 | $224K | Hold |
2,690
| – | – | 0.18% | 153 |
|
|
2018
Q3 | $290K | Hold |
2,690
| – | – | 0.2% | 153 |
|
|
2018
Q2 | $296K | Hold |
2,690
| – | – | 0.21% | 152 |
|
|
2018
Q1 | $270K | Hold |
2,690
| – | – | 0.19% | 154 |
|
|
2017
Q4 | $265K | Hold |
2,690
| – | – | 0.18% | 156 |
|
|
2017
Q3 | $252K | Hold |
2,690
| – | – | 0.19% | 152 |
|
|
2017
Q2 | $299K | Hold |
2,690
| – | – | 0.23% | 139 |
|
|
2017
Q1 | $264K | Sell |
2,690
-130
| -5% | -$12.4K | 0.21% | 146 |
|
|
2016
Q4 | $259K | Buy |
2,820
+340
| +14% | +$29.3K | 0.21% | 145 |
|
|
2016
Q3 | $210K | Hold |
2,480
| – | – | 0.18% | 152 |
|
|
2016
Q2 | $202K | Buy |
+2,480
| New | +$189K | 0.18% | 155 |
|
Other funds holding DGX
EIG
Mitchell McLeod Pugh & Williams's DGX Position: Q2 2026 in Review
Mitchell McLeod Pugh & Williams increased its Quest Diagnostics (DGX) stake by 3% in Q2 2026, buying an estimated $14.9K and bringing the position to 2,570 shares worth $545K. The position accounts for 0.07% of the portfolio, ranked #204.
Mitchell McLeod Pugh & Williams first reported a position in DGX in Q2 2016 and has held it in 41 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Mitchell McLeod Pugh & Williams held 2,570 shares of Quest Diagnostics worth $545K as of Q2 2026.
- Mitchell McLeod Pugh & Williams bought 76 Quest Diagnostics shares in Q2 2026, an estimated $14.9K.
- Quest Diagnostics made up 0.07% of Mitchell McLeod Pugh & Williams's portfolio in Q2 2026, its #204 holding.
- Mitchell McLeod Pugh & Williams first reported a position in Quest Diagnostics in Q2 2016 and has held it in 41 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2026, filed 11 Aug 2026.